BNTX
BioNTech SE
NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY
$103.45
+1.85% today
Updated 2026-04-30
Market cap
$25.69B
P/E ratio
—
P/S ratio
8.95x
EPS (TTM)
$-5.50
Dividend yield
—
52W range
$80 – $124
Volume
1.2M
BioNTech SE (BNTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $389.96M | $374.71M | $652.99M | $797.65M | $2.32B | $15.83B | $23.28B | $23.01B | $22.53B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — |
| Current assets | $318.13M | $189.64M | $448.96M | $560.15M | $1.67B | $15.07B | $21.92B | $19.53B | $18.80B |
| Total liabilities | $358.10M | $422.92M | $385.99M | $304.15M | $946.80M | $3.94B | $3.22B | $2.76B | $3.12B |
| Current liabilities | $56.64M | $158.54M | $126.12M | $138.14M | $606.00M | $3.48B | $2.95B | $2.07B | $2.52B |
| Long-term debt | $0.00 | $0.00 | $5.60M | $68.90M | $231.05M | $171.60M | $176.20M | $191.00M | $214.70M |
| Shareholder equity | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-112.10M | $-197.75M | $-245.77M | $-424.83M | $-409.60M | $9.88B | $18.83B | $19.76B | $19.10B |
| Accounts receivable | $5.97M | $4.58M | $28.44M | $20.20M | $165.50M | $12.38B | $7.15B | $2.34B | $1.52B |
| Inventory | $3.27M | $3.88M | $5.79M | $11.72M | $64.10M | $502.50M | $439.60M | $357.70M | $283.30M |
| Goodwill | $534000.00 | $534000.00 | $534000.00 | $2.98M | $53.70M | $57.80M | $61.20M | $362.50M | $380.60M |